Related Experiment Video
Updated: Sep 16, 2025

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.5K
Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?
Oral Mentes1, Deniz Celik2, Murat Yıldız3
1Department of Intensive Care, Gulhane Training and Research Hospital, 06010 Ankara, Turkey.
Diagnostics (Basel, Switzerland)
|July 12, 2025
Summary
Atrial fibrillation (AF) is common in patients with hypercapnic type 2 respiratory failure, significantly increasing mortality risk. Early screening for AF during intensive care unit admissions is crucial for better patient outcomes.
Area of Science:
- Critical Care Medicine
- Cardiology
- Pulmonology
Background:
- Atrial fibrillation (AF) is a common comorbidity in patients with hypercapnic type 2 respiratory failure.
- AF can negatively impact patient outcomes in this population.
- Understanding the clinical features and prognostic value of AF is essential.
Purpose of the Study:
- To investigate the clinical characteristics of patients with hypercapnic type 2 respiratory failure and atrial fibrillation.
- To determine the prognostic significance of atrial fibrillation in this patient group.
- To evaluate the association between AF and mortality risk.
Main Methods:
- Retrospective, single-center study of 200 adult patients with hypercapnic type 2 respiratory failure.
- Patients categorized based on the presence or absence of atrial fibrillation.
- Demographic, clinical, laboratory, echocardiographic data, and outcomes were analyzed.
- Kaplan-Meier survival analysis and Cox regression identified mortality predictors.
Main Results:
- Atrial fibrillation was present in 50.5% of patients.
- AF patients were older, had more comorbidities, and higher rates of heart failure.
- AF was associated with poorer survival and a 1.6-fold increased mortality risk.
- Advanced age and low hemoglobin independently predicted mortality.
Conclusions:
- Atrial fibrillation is prevalent in type 2 respiratory failure and independently associated with increased mortality.
- Anticoagulant treatment for AF was underutilized in this cohort.
- Active screening for AF in ICU patients with respiratory failure is recommended.
Related Concept Videos
Acute Respiratory Failure-I
340
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
340
Acute Respiratory Failure-III
330
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
330
Acute Respiratory Failure-V
212
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
212
Acute Respiratory Failure-IV
235
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
235
Acute Respiratory Failure-II
371
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
371
Flail Chest-II
237
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
237

